B P6 C54 Hypertrophic Cardiomopathy Flashcards

1
Q

Hypertrophic cardiomyopathy (HCM) is a primary disorder of the myocardium.

It is defined by the presence of _____.

A
  • Unexplained left ventricular hypertrophy (LVH) * Absence of identifiable factors that may account for increased left ventricular wall thickness, including pressure overload and infiltrative or storage disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Classically, _____ are present histologically

A
  • Myocyte hypertrophy
  • Disarray
  • Myocardial fibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Familial disease is well characterized, and pathogenic variants in the genes encoding the cardiac _____ are the most common etiology of HCM

A

Sarcomere

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A maximum left ventricular wall thickness of ≥15 mm has been the standard threshold to diagnose disease in adults, although a threshold of≥13 mm is recommended if there is a family history of HCM or if the individual in question carries a disease-causing (pathogenic) sarcomeric gene variant.

A

MAXIMUM LV WALL THICKNESS

Standard: ≥ 15 mm
Family hx of HCM: ≥ 13 mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

At the histopathologic level, HCM is characterized by myocyte hypetrophy, disarray, and fibrosis. These intrinsic tissue abnormalities, particularly _____, likely contribute to clinical manifestations of heart failure (systolic and diastolic) and to the genesis of arrhythmias (ventricular and atrial)

A

Myocyte hypertrophy
Myocardial fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The location and degree of hypertrophy are variable, and ventricular volumes are typically small. Although _____ is the classic and most common morphologic subtype of HCM, hypertrophy can involve any left ventricular (LV) segment and may be focal or concentric

A

Asymmetric septal hypertrophy resulting in reversed septal curvature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Apical HCM is a well-described morphologic variant in which hypertrophy involves the _____.

A

Distal LV, below the level of the papillary muscles

As such, apical HCM is NOT associated with left ventricular outflow tract obstruction (LVOTO).

Apical HCM was first reported in Japan and is more prevalent in individuals of Japanese versus European descent (13% to 25% vs. 1% to 2%). Although early studies suggested a more benign prognosis for apical HCM, a broad spectrum of clinical outcomes has been described.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Patients with classic reversed septal curvature are most likely to have _____ whereas patients with a sigmoidal septum (discrete upper septal thickening) or apical hypertrophy are least likely to have sarcomeric disease. This latter pattern of hypertrophic remodeling is relatively common in older adults with hypertension and thus nonspecific.

A

Pathogenic sarcomeric gene variants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The differential diagnosis for HCM includes other conditions that may also result in increased left ventricular wall thickness, including _____.

A
  • Syndromic, metabolic, storage, or infiltrative disorders (e.g., Noonan syndrome/RASopathies, Fabry disease, Pompe disease, cardiac amyloidosis, mitochondrial disease)
  • Compensatory or secondary hypertrophic heart disease attributed to pressure overload (hypertension) or intense athletic training
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Seminal genetic studies performed on families with HCM in the 1980s to 1990s established that HCM is a disease of the sarcomere—most frequently caused by pathogenic variation in genes encoding cardiac-specific sarcomeric proteins, particularly _____.

A

Myosin binding protein C (MYBPC3) - 55%
Myosin heavy chain (MYH7) - 32%
Troponin T (TNNT2)
Troponin I (TNNI3)
Myosin light chains (MYL2 and MYL3)
Alpha-tropomyosin (TPM1)
Actin (ACTC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Variants in _____ are most common; collectively responsible for over 80% of sarcomeric HCM (caused by pathogenic sarcomeric variants identified by genetic testing)

A

MYBPC3 (55%) and MYH7 (32%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The population prevalence of ___ is approximately 1:500, making it the most common monogenic heart disease

A

HCM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

At the cellular level, abnormal calcium handling and altered interaction between actin-myosin has been identified, leading to abnormal _____.

A

Contraction and relaxation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Coupled with the inherent stiffness of the hypertrophied left ventricle, some degree of _____ dysfunction is present in nearly all patients with HCM

A

Diastolic dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Early diastolic tissue Doppler velocities are _____ in most patients with HCM, and abnormalities can be identified before the development of overt LVH in individuals who carry pathogenic sarcomeric variants

A

Reduced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Because the capillary network is less dense in HCM, _____ ischemia is readily manifest and can further worsen diastolic function.

A

Subendocardial ischemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Moreover, calculated LVEF may not be a reliable measure of overall systolic function in HCM as the small LV cavity size associated with HCM is in the denominator of the formula and may artificially elevate ejection fraction. Accordingly, patients with HCM are considered to have significantly impaired systolic function if the ejection fraction less than _____%.

A

< 50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

The most clinically apparent, and treatable, pathophysiologic mechanism in HCM is that of _____.

A

LVOTO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Obstruction is present at rest or with physiologic provocation in up to two-thirds of patients with HCM and occurs as the hypertrophied septum redirects flow across, rather than along the mitral valve, which causes _____, further narrowing the outflow tract.

The mitral valve itself is often elongated and positioned more _____, which amplifies this effect

A

Systolic anterior motion (SAM)

Anteriorly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

The anterior mitral leaflet, rather than closing normally, is pushed further into the outflow tract, narrowing the latter and interfering with coaptation.

Together, this results in increased ____ and _____, particularly in late systole, increased _____, and _____ directed mitral regurgitation

A

Increase:
LV systolic pressure
Obstruction to flow (Late systole)
Increased myocardial O2 demand

Posteriorly directed MR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Patients are considered to have obstructive physiology if they have maximum instantaneous gradients across the outflow tract of at least _____ mm Hg.

Resting or provoked gradients exceeding ____ mm Hg are considered capable of causing limiting symptoms.

Patients with effort-related symptoms and resting LVOT gradients less than ___ mm Hg should have provocative maneuvers included with noninvasive evaluation

A

MIG:
30 mm Hg

Resting or provoked gradients > 40-50 mm Hg (limiting symptoms)

Symptoms + Resting LVOT gradient < 40 mm Hg
-> Provocative maneuvers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Bedside maneuvers such as _____ can be helpful in identifying latent outflow obstruction.

Provocation with exercise (e.g.,exercise echocardiography) is a highly relevant and physiologic method to assess effort intolerance and should be considered in patients with symptoms whose resting gradients are not sufficiently high to account for their symptoms

A

Valsalva or squat-to-stand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Aggressive ____ or restoration of _____, both in combination with oral anticoagulation are felt to be important for patients with HCM

A

Rate control

Sinus rhythm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Overall morbidity in HCM is dominated by heart failure and atrial fibrillation. Similarly, mortality is driven by complications of _____, both of which are more common than lethal arrhythmias

A

Heart failure and noncardiac death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Sex also impacts the clinical course in HCM. _____ are typically diagnosed at an older age and typically have more symptomatic heart failure and higher mortality.

A

Females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

The majority of these HCM-related complications occur later in life, becoming most prevalent by _____ adulthood, even in patients diagnosed before age 40 years

A

Middle to late adulthood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Approximately _____% of patients with HCM experience more advanced cardiac remodeling marked by a decrease in LV systolic function.

Because HCM is characteristically associated with increased LVEF, an LVEF of _____% or less is abnormal and has traditionally defined HCM with LV systolic dysfunction (HCM-LVSD).

A

8%

50% or less

28
Q

Risk predictors for incident development of systolic dysfunction included the presence of _____.

A
  • Pathogenic sarcomeric variants, particularly in thin filament genes
  • Increased LV wall thickness
  • Left ventricular dilation
  • Borderline low ejection fraction (50% to 59%)
29
Q

Risk predictors of poor prognosis for patients with HCM-LVSD are _____.

A
  • Multiple pathogenic/likely pathogenic sarcomeric variants
  • Atrial fibrillation
  • LVEF less than 35%
30
Q

The goals of genetic testing are to _____.

A

(1) Provide a definitive diagnosis in patients with known or suspected HCM

(2) Guide management of at-risk or undiagnosed relatives

31
Q

Diagnostic genetic testing is performed on an individual with _____, typically using multigene panels specifically tailored for HCM that include at least the core sarcomeric genes (MYH7,MYBPC3,TNNT2,TNNC1,TNNI3,TPM1, MYL2, MYL3, ACTC1), as well as genes associated with other conditions that result in increased LV wall thickness, including glycogen storage disease and lysosome storage diseases (LAMP2,PRAKAG2,GLA [Fabry disease], GAA [Pompe disease]), metabolic and mitochondrial disease, hereditary amyloidosis (TTR), and other genetic syndromes such as Noonan syndrome (involving genes in the Ras/MAP kinase pathway)

A

Unexplained LVH or a clinical diagnosis of HCM

32
Q

The initial step in family management is to obtain a _____, ideally in pedigree format, to capture family structure, medical diagnoses and events, and ages and causes of death.

A

Multigenerational family history

33
Q

If familial disease is confirmed or cannot be excluded, clinical screening is performed to _____.

A

(1) Identify affected relatives
(2) Follow currently unaffected relatives who are at risk for developing clinical disease.

34
Q

For adult and adolescent first-degree relatives of patients with HCM, screening is recommended to commence at the _____.

A
  • Time of diagnosis in the proband
  • Repeated at regular intervals
    Late childhood - adolescence: every 1 to 2 years
    Adulthood: every 5 years
35
Q

For younger children, clinical screening can commence at any time but no later than the ______.

Earlier initiation of screening can be considered if there is a _____.

A

Onset of puberty

  • Family history of early-onset HCM,
  • Particularly malignant history of HCM-related adverse outcomes
  • Heightened parental concern
36
Q

For children and adolescents, once clinical screening is initiated, the repeat surveillance interval is every _____ years.

A

Every 1-2 years

37
Q

If a definitively pathogenic variant is identified by diagnostic genetic testing on an affected family member, _____ testing can be offered to relatives to determine whether the variant has been inherited in other relatives.

A

Focused predictive or variant confirmation genetic testing

38
Q

As mentioned earlier, SCD occurs in
Hypertrophic Cardiomyopathy just less than ____% of patients with HCM each year, and the appropriate utilization of ICDs has resulted in significantly improved outcomes.

A

< 1%

39
Q

_____ have all been identified as being associated with SCD.

A
  • Massive LV wall thickness (either as a binary variable or as a continuous variable)
  • Syncope felt to be arrhythmogenic
  • Family history of SCD
  • Overt systolic dysfunction
  • LV apical aneurysm
  • Nonsustained ventricular tachycardia (NSVT)
  • Extensive intramyocardial scarring (as assessed with CMR)
40
Q

_____ has also been shown to be associated with SCD, but the effect size is modest and given the inherently dynamic nature of obstruction, this metric can be problematic to use in practice

A

Severe LVOTO

41
Q

In adult patients, the risk markers that appear to carry the most significance are _____.

A
  • Massive hypertrophy (wall thickness approaching or exceeding 30 mm)
  • Family history of SCD in first-degree relatives younger than the age of 40 to 50 (or potentially multiple second-degree relatives)
  • Arrhythmogenic syncope
  • LV systolic dysfunction
  • LV apical aneurysm
42
Q

Apart from SCD risk stratification, management of patients with HCM has traditionally focused on _____.

Although clinical trial evidence is relatively scant, no pharmacologic agent has been shown to improve survival, and no invasive therapy has been shown to alter mortality in asymptomatic patients.

A

Symptom management

***This means that asymptomatic patients do not require initiation of therapy

43
Q

_____ that vary from day to day are the hallmark symptoms attributable to LVOTO.

A

Dyspnea
Chest pain/pressure
Presyncope

44
Q

Because gradient is highly dependent on loading conditions, anything that causes _____ may exacerbate symptoms.

A
  • Systemic vasodilation (e.g., ambient temperature, postprandial state, alcohol consumption)
  • Volume depletion
45
Q

Symptoms are most dramatically promoted by physical effort as _____.

A

Systemic vascular resistance drops
Contractility is augmented

46
Q

Although randomized clinical trials have not been performed, the general approach for symptomatic patients with obstructive physiology is to _____.

A
  • Optimize volume status (encourage vigorous hydration)
  • Eliminate or reduce any vasodilator therapies
  • Empirically start beta blockers, verapamil, or diltiazem because these agents have negative chronotropic effects which help maximize preload by increasing the diastolic filling interval, and negative inotropic effects
47
Q

Persistent symptoms beyond this prompts consideration of advanced options including _____.

A

Disopyramide (added to one of the other agents)

48
Q

Although medical therapies are used to target myocardial function and/or loading conditions to indirectly improve obstruction,_____ directly addresses the anatomic cause of obstruction.

A

Septal reduction therapy (surgical septal myectomy or alcohol septal ablation)

49
Q

_____ myectomy has evolved since its introduction over 60 years ago. Performed via an aortotomy, muscle resection is now extended and involves a larger surface area of the septum down to the level of the papillary muscles. Some operators also include plication or other manipulation of the anterior mitral leaflet, particularly if mitral regurgi- tation or mitral valve pathology is thought to contribute importantly to pathophysiology.

A

Septal myectomy

50
Q

Successful myectomy normalizes the _____ in the ventricle such that the mitral valve can _____ normally and outflow tract gradient is substantially _____.

Muscle does not “regrow” at the myectomy site; therefore results are durable (recurrent or residual obstruction likely results from inadequate initial resection). In experienced centers, operative (30-day) mortality is less than 1% with a 90% to 95% success rate

A

Normalizes the flow pattern in the ventricle such that the mitral valve can coapt normally and outflow tract gradient is substantially reduced or abolished.

51
Q

Septal ablation is a percutaneous procedure during which alcohol is infused into the _____ that supplies the obstructive hypertrophied septum. This results in a scar which causes retraction of the septum as the myocardium remodels post infarct

A

Septal perforator artery

52
Q

However, there is a higher need for ____ following ablation, and higher rate of _____.

A

Higher:
Reintervention
Heart block requiring permanent pacemaker placement

53
Q

Patients who have other cardiovascular disease requiring surgical intervention are usually treated with _____.

A

Surgical myectomy

54
Q

____ appear to have better outcomes with surgery.

Patients who are ____ that makes a surgical approach riskier are better candidates for septal ablation.

A

Better outcomes with surgery in:
* Younger patients,
* More severe LVH (>18 mm)
* Severe resting gradients (>100 mm Hg)

Better outcomes with septal ablation:
* Frail or have significant comorbidity

55
Q

Patients who are frail or have significant comorbidity that makes a surgical approach riskier are better candidates for ____.

A

Septal ablation

56
Q

Empiric treatment for patients with nonobstructive HCM also uses _____ as first agents.

_____ are used for patients with persistent dyspnea and/or signs of congestion.

A

Beta blockers, verapamil, or diltiazem

Diuretics

57
Q

It has been estimated that up to _____ of patients with HCM may experience atrial fibrillation, with prevalence increasing with age.

A

Half

58
Q

The onset of atrial fibrillation can substantially reduce preload through loss of atrial contribution to LV filling, and as heart rates increase, the diastolic filling period is truncated.

Slowing the heart rate and restoring sinus rhythm are important targets for therapy. _____ can be helpful for rate control, and _____ have all be used for rhythm control

A

Rate control:
Beta blockers
Verapamil
Diltiazem

Rhythm control:
Amiodarone
Dofetilide
Disopyramide
Sotalol

59
Q

The risk of thromboembolism in patients with HCM and AF is higher than in patients without structural heart disease. As such, risk-scoring systems (e.g., CHADs2VASc) are not used in patients with HCM, but rather oral anticoagulation is considered appropriate in _____.

A

All patients with both HCM and AF

60
Q

Direct oral anticoagulants or warfarin are considered as viable options in patients with HCM.

As with other patients with AF lasting more than ____ hours, the recommendation for oral anticoagulation is clear.

A

> 24 hours

For AF episodes less than 24 hours, the choice to initiate anticoagulation would need to be individualized accounting for bleeding risk, total AF burden, and other risk factors for thromboembolism.

61
Q

The challenge is that among competitive athletes who have had cardiac arrest,HCM is overrepresented as an underlying diagnosis.This fact led to a generalized _____ of individuals with HCM from participation in competitive athletics regardless of their clinical status.

A

Exclusion

62
Q

From a practical standpoint, each person with HCM who is interested in higher-intensity training must be informed of this ____.

A
  • The risk (Of cardiac arrest)
  • The inability to accurately estimate the risk
  • Determine his or her own level of tolerance for the unknown risk
63
Q

Class I indication of ICD implantation in patients with HCM

A

Prior event (SCD, VF or sustained VT)

64
Q

Class IIa indication of ICD implantation in patients with HCM

A

NO Prior event of SCD, VF or sustained VT

With at least 1 of the following:
* FH SCD
* Massive LVH
* Unexplained syncope
* Apical aneurysm
* EF less than or equal to 50%
* Nonsustained VT in children

65
Q

Class IIb indication of ICD implantation in patients with HCM

A
  • Nonsustained VT in adults
  • Extensive LGE on CMR
66
Q

Class III recommendation for ICD implantation in patients with HCM

A
  • No prior event of SCD, VF or sustained VT
  • No major risk factors
  • No NSVT
  • No extensive LGE on CMR
67
Q

_____ in ECG is commonly associated with apical HCM.

A

Marked T wave inversion